Markets:

Overview

News

Currencies

International

Treasuries

Seagen Inc. - Common Stock (NQ:SGEN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Seagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

How To Invest In The Healthcare Sector ↗

August 19, 2023

If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how...

Via Talk Markets

Seagen's Positive Trial Outcomes: Analyst Says The Update Might Double Tukysa's Current Market ↗

August 16, 2023

Earlier today, Seagen Inc (NASDAQ: SGEN) announced that the Phase 3 HER2CLIMB-02 clinical trial of Tukysa (tucatinib) in combination with the antibody-drug conjugate ado-trastuzumab emtansine (Kadcyla)...

Via Benzinga

Win For Pfizer? Seagen's Cancer Combo Therapy Hits Primary Goal In Late-Stage Breast Cancer Study ↗

August 16, 2023

Seagen Inc (NASDAQ: SGEN) announced that the Phase 3 HER2CLIMB-02 clinical trial of Tukysa (tucatinib) in combination with the antibody-drug conjugate ado-trastuzumab emtansine (Kadcyla) met its...

Via Benzinga

Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer

August 16, 2023

From Seagen Inc.

Via Business Wire

If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,600 Today ↗

August 10, 2023

Via Benzinga

Seagen Earnings Preview ↗

August 01, 2023

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $17,000 Today ↗

July 31, 2023

Via Benzinga

3 Pharmaceutical Stocks to Buy and Hold for the Long Haul

August 11, 2023

Robust pipelines make these three pharmaceutical stocks solid choices for investors looking for stocks to buy and hold for long-term gains

Via MarketBeat

3 Cheap Long-Term Stocks That Smart Investors Will Snap Up Now ↗

August 06, 2023

These cheap long-term stocks are a good way to play the current market uncertainty and round out your portfolio.

Via InvestorPlace

Seagen Second Quarter 2023 Financial Results Demonstrate Exceptional Commercial Performance Driving Record Product Sales with Strong Growth and Momentum

August 02, 2023

From Seagen Inc.

Via Business Wire

Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated ↗

July 28, 2023

Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of

Via Benzinga

How Is The Market Feeling About Seagen? ↗

July 19, 2023

Via Benzinga

$100 Invested In Seagen 10 Years Ago Would Be Worth This Much Today ↗

July 10, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Seagen Stock In The Last 20 Years ↗

June 23, 2023

Via Benzinga

3 Undervalued Large-Cap Stocks That Won't Be for Long

July 20, 2023

Buying undervalued stocks that have unrealized catalysts will rarely disappoint investors who have the discipline to hold them over time.

Via MarketBeat

"Rule Breaker Investing" Market Cap Game Show: A Battle of Wits ↗

July 15, 2023

Sometimes you know the market cap, sometimes you're just guessing.

Via The Motley Fool

3 Pharma Stocks That AI is Loving in July ↗

July 13, 2023

Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.

Via InvestorPlace

3 Healthcare Stocks With Healthy Dividends ↗

July 13, 2023

These pharmaceutical companies all combine relatively high dividends with safe payout ratios.

Via The Motley Fool

Seagen to Report Second Quarter 2023 Financial Results on August 2, 2023

July 12, 2023

From Seagen Inc.

Via Business Wire

Activision Stock Jumps As U.S. Judge Clears Hurdle To Microsoft Buyout ↗

July 11, 2023

Activision stock rocketed after a court allowed Microsoft to proceed with its $69 billion acquisition of the video game publisher.

Via Investor's Business Daily

From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs ↗

July 07, 2023

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as...

Via Benzinga

Best Under-the-Radar Stocks: 3 That AI Predicts Will Soar in July ↗

July 04, 2023

Bard outperformed other AI models and even beat a human reporter in stock picking. It believes these under-the-radar stocks will soar in July.

Via InvestorPlace

The 7 Most Undervalued S&P 500 Stocks to Buy Now ↗

July 02, 2023

Undervalued S&P 500 stocks offer the stability of a well-established share at discount prices investors appreciate.

Via InvestorPlace

Activision Blizzard Shares up 1.83% Amid Regulators' Blunders

June 27, 2023

Shares of Microsoft Corp. (NASDAQ: MSFT) declined 1.92% on June 26, more than the broader market, while Activision Blizzard Inc. (NASDAQ: ATVI) rose 1.83%. The S&P 500 declined 0.41% in the session.

Via MarketBeat

Topics Stocks

ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials

June 26, 2023

ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t

Via MarketBeat

5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies ↗

June 20, 2023

Via Benzinga

Phase 3 Trial of ADCETRIS® (brentuximab vedotin) with Modified Chemo Regimen Shows Non-Inferiority with Unprecedented 3-Year Progression Free Survival of 94.9% vs Less Tolerable International Standard of Care in Advanced Classical Hodgkin Lymphoma

June 20, 2023

From Seagen Inc.

Via Business Wire

3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever ↗

June 20, 2023

Here are three long-term biotech stock investments that have the opportunity to turn risk -tolerant investors into millionaires.

Via InvestorPlace

Unlock the Potential of These 7 Cash-Flow Machines ↗

June 18, 2023

Here are seven high cash flow stocks that provide investors with both growth and value under any economic conditions.

Via InvestorPlace

How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities ↗

June 17, 2023

The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators...

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.